New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and ...

The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will fuel a new wave of genetic medicine. | University of California spinout ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...

Cellular Origins is a UK‑based company enabling scalable, factory‑led automation for cell and gene therapy manufacturing, and ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...